The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry and FDA Staff: Minimal Manipulation of Structural Tissue Jurisdictional Update

Origin/Publisher:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/

Document Type:
Guidance for Industry and FDA Staff
Content:
This guidance document provides information about the classification of products as human cells, tissues and cellular and tissue-based product (HCT/P's) regulated solely under section 361 of the Public Health Service Act (PHS Act). Specifically, this guidance document discusses FDA's current thinking on the meaning of the phrase "minimally manipulated" contained in 21 CFR 1271.10(a)(1), and defined ("minimal manipulation") at 21 CFR 1271.3(f), as it applies to structural tissue.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK